The Oncology Institute, Inc. (TOI) NASDAQ
4.62
-0.1555(-3.25%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
4.62
-0.1555(-3.25%)
Currency In USD
| Previous Close | 4.78 |
| Open | 4.79 |
| Day High | 4.79 |
| Day Low | 4.49 |
| 52-Week High | 4.89 |
| 52-Week Low | 2.02 |
| Volume | 858,736.3 |
| Average Volume | 1.87M |
| Market Cap | 462.37M |
| PE | -13.21 |
| EPS | -0.35 |
| Moving Average 50 Days | 3.68 |
| Moving Average 200 Days | 3.48 |
| Change | -0.16 |
The Oncology Institute Announces Fourth Quarter and Full Year 2025 Earnings Release Date and Conference Call
GlobeNewswire Inc.
Feb 26, 2026 1:00 PM GMT
CERRITOS, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (“TOI”) (NASDAQ: TOI) a pioneer in value-based community oncology care, today announced that the company will release its fourth quarter and full year 2025 financial
The Oncology Institute to Participate in Multiple Healthcare Investor Conferences in March
GlobeNewswire Inc.
Feb 25, 2026 1:00 PM GMT
CERRITOS, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), a pioneer in value-based community oncology care, today announced that members of its executive leadership team will participate in several investor con
The Oncology Institute Appoints Kim Tzoumakas to Board of Directors
GlobeNewswire Inc.
Feb 23, 2026 1:00 PM GMT
CERRITOS, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (“TOI”) (NASDAQ: TOI), one of the largest value-based oncology groups in the United States, today announced the appointment of Kim Tzoumakas to its Board of Directors,